This generally well-conducted review concluded that, for patients undergoing spinal fusion surgery for lumbar spine degenerative disease, circumferential fusion could increase the fusion rate and reduce the reoperation rate compared with instrumented posterolateral fusion, but it also increased the complication rate and blood loss. However, variable patient characteristics and small sample sizes reduce the reliability of the authors' cautious conclusions.
Study selection
Randomised controlled trials (RCTs) of instrumented posterolateral fusion and circumferential fusion in adult patients who underwent spinal fusion surgery for degenerative disease of the lumbar spine were eligible for inclusion. Trials had to follow patients up for at least one year after surgery. Patients with acute spinal fracture, infection, tumour, osteoporosis or rheumatoid arthritis were excluded.
The primary outcomes of interest were global assessment of clinical outcomes and complication rate. Secondary outcomes were fusion rate, blood loss, operating time and reoperation time. Trials were excluded if they did not report on at least one relevant outcome.
Included trials compared posterolateral fusion combined with titanium CD-horizon, posterolateral fusion combined with variable screw placement or instrumented posterolateral fusion versus circumferential fusion plus an anterior lumbar interbody fusion Brantigan cage plus posterior instrumentation, posterolateral fusion plus transforaminal lumbar interbody fusion, posterolateral fusion plus posterior lumbar interbody fusion, or posterolateral fusion combined with variable screw placement and interbody fusion. The mean age of patients ranged from 42 to 58.6 years.
Two reviewers independently performed study selection; disagreements were resolved by discussion or consultation with a third reviewer.
Assessment of study quality
Two reviewers independently assessed trial quality according to criteria established by Koes et al, using 16 quality items including drop-outs, homogeneity, blinding and intention-to-treat. Each trial was given a score out of 100, with trials scoring more than 60 points deemed best studies. Disagreements between reviewers were resolved by consensus.
Data extraction
Two reviewers independently extracted data on the primary and secondary outcomes, and used the data to calculate odds ratios (OR) or mean differences, together with 95% confidence intervals (CI). Disagreements between reviewers were resolved by consensus.
Methods of synthesis
A random-effects meta-analysis was undertaken to calculate pooled odds ratios or weighted mean differences (WMD), together with 95% confidence intervals. Statistical heterogeneity was assessed using the I 2 statistic and X 2 test.
